Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: The PAKT trial

1. Schmid, P.
2. Abraham, J.
3. Chan, S.
4. Wheatley, D.
5. Brunt, A.M.
6. Nemsadze, G.
7. Baird, R.D.
8. Park, Y.H.
9. Hall, P.S.
10. Perren, T.
11. Stein, R.C.
12. Mangel, L.
13. Ferrero, J.-M.
14. Phillips, M.
15. Conibear, J.
16. Cortes, J.
17. Foxley, A.
18. de Bruin, E.C.
19. McEwen, R.
20. Stetson, D.
21. Dougherty, B.
22. Sarker, S.-J.
23. Prendergast, A.
24. McLaughlin-Callan, M.
25. Burgess, M.
26. Lawrence, C.
27. Cartwright, H.
28. Mousa, K.
29. Turner, N.C.
30. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1200/JCO.19.00368 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus